安慰剂对照低剂量氯胺酮复合瑞芬太尼靶控输注用于取卵镇静
该双盲随机对照研究在取卵患者中比较瑞芬太尼靶控输注镇静下加用低剂量氯胺酮或安慰剂对呼吸抑制的影响,121例完成研究,结果显示低剂量氯胺酮未减少呼吸抑制发生率和严重程度,但降低疼痛评分和瑞芬太尼浓度并减少术后恶心,仍需持续监测二氧化碳波形和氧饱和度。
要点
- 低剂量氯胺酮未减少瑞芬太尼镇静下呼吸抑制发生率。
- 氯胺酮组疼痛评分和瑞芬太尼效应室浓度显著降低。
- 氯胺酮组术后恶心发生率低于对照组。
核心结论
- 在瑞芬太尼靶控输注清醒镇静下加用低血浆浓度氯胺酮未降低呼吸抑制的发生率或严重程度。
- 始终需要持续监测二氧化碳波形和氧饱和度。
研究设计与样本
- 控制、随机、前瞻性、双盲研究,在比利时布鲁塞尔一家三级医院于2013年12月至2014年6月进行。
- 共纳入132例取卵女性,121例完成研究。
- 随机后患者接受氯胺酮输注(5分钟内40 μg kg min,随后2.5 μg kg min)或0.9%生理盐水输注,均复合可变瑞芬太尼靶控输注。
主要发现
- 呼吸事件发生率无显著差异:脉搏血氧饱和度<95%在氯胺酮组为49%,对照组为63%(P = 0.121)。
- 无患者需要通气支持。
- 氯胺酮组视觉模拟疼痛评分和瑞芬太尼浓度显著降低,但后者仍高于2 ng ml。
- 氯胺酮组术后恶心发生率更低,为4% versus 15%(P = 0.038)。
- 加用氯胺酮未影响住院时间或患者满意度。
临床怎么用
- 取卵镇静中加用低剂量氯胺酮不能替代呼吸监测,应始终持续监测二氧化碳波形和氧饱和度。
- 低剂量氯胺酮可降低疼痛评分和瑞芬太尼浓度,并减少术后恶心,但未减少呼吸抑制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Currently, there is no gold standard for monitored anaesthesia care during oocyte retrieval. OBJECTIVE: In our institution, the standard is a conscious sedation technique using a target-controlled infusion (TCI) of remifentanil, titrated to maintain a visual analogue pain score less than 30 mm. This protocol is well accepted by patients but is associated with frequent episodes of respiratory depression. The main objective of this study was to evaluate whether the addition of a continuous intravenous infusion of ketamine could reduce these episodes. DESIGN: Controlled, randomised, prospective, double-blinded study. SETTING: The current study was conducted in a tertiary-level hospital in Brussels (Belgium) from December 2013 to June 2014. PATIENTS: Of the 132 women undergoing oocyte retrieval included, 121 completed the study. INTERVENTION: After randomisation, patients received either a ketamine infusion (40 μg kg min over 5 min followed by 2.5 μg kg min) or a 0.9% saline infusion in addition to the variable remifentanil TCI. MAIN OUTCOME MEASURES: The primary outcome was the number of respiratory depression episodes. Effect site target remifentanil concentrations, side effects, pain score, patient satisfaction and incidence of pregnancy were also recorded. RESULTS: No significant difference in the incidence of respiratory events was noted (pulse oximetry oxygen saturation < 95% was 49% in the ketamine group and 63% in the control group; P = 0.121). No patient required ventilatory support. In the ketamine group, visual analogue pain score and remifentanil concentrations were significantly reduced, but the latter remained above 2 ng ml. Postoperative nausea was less frequent in the ketamine group, 4 versus 15% (P = 0.038). The addition of ketamine did not influence length of stay nor patient satisfaction. CONCLUSION: The addition of low plasma levels of ketamine to a TCI remifentanil conscious sedation technique did not decrease the incidence nor the severity of respiratory depression. Continuous monitoring of capnography and oxygen saturation is always required. TRIAL REGISTRATION: EUDRACT number 2013-003040-23.
引用
- Morue HI, Raj-Lawrence S, Saxena S, et al. Placebo versus low-dose ketamine infusion in addition to remifentanil target-controlled infusion for conscious sedation during oocyte retrieval: A double-blinded, randomised controlled trial. Eur J Anaesthesiol. 2018. PMID: 29757924. doi:10.1097/EJA.0000000000000826
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。